SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-002818
Filing Date
2020-08-19
Accepted
2020-08-19 16:31:25
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannapharmarx_10q-063020.htm 10-Q 591972
2 CERTIFICATION canna_ex3101.htm EX-31.1 11559
3 CERTIFICATION canna_ex3102.htm EX-31.2 11216
4 CERTIFICATION canna_ex32.htm EX-32 4996
  Complete submission text file 0001683168-20-002818.txt   3461147

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20200630.xml EX-101.INS 481733
6 XBRL SCHEMA FILE cpmd-20200630.xsd EX-101.SCH 39273
7 XBRL CALCULATION FILE cpmd-20200630_cal.xml EX-101.CAL 58561
8 XBRL DEFINITION FILE cpmd-20200630_def.xml EX-101.DEF 193541
9 XBRL LABEL FILE cpmd-20200630_lab.xml EX-101.LAB 284823
10 XBRL PRESENTATION FILE cpmd-20200630_pre.xml EX-101.PRE 260067
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 201117408
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences